Liposomal and Standard Bupivacaine in Thoracic Paravertebral Block for Post-Thoracoscopic Pain
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorYongtao Sun
About this trial
I. Research purpose
1.1 Main Objective: To investigate the efficacy and safety of bupivacaine liposome thoracic paravertebral nerve block for postoperative analgesia after thoracoscopic lobectomy
1.2 Exploratory Objective: To investigate the noninferiority of bupivacaine liposomes in thoracic paravertebral nerve block with standard bupivacaine
Eligibility criteria
Qualifiers
1) Age ≥18 years old;
Disqualifiers
1) Pregnant or lactating women;
Trial design
Treatments tested in this trial
- GroupB:Liposomal bupivacaine and bupivacaine hydrochloride;
- Group A: bupivacaine hydrochloride;
Treatment groups
496 Participants
are divided into 2 treatment groupsSponsors and collaborators
Yongtao Sun
Lead sponsor
Qianfoshan Hospital
Sponsor institution
Source ClinicalTrials.gov